BACKGROUND: Metabolic phenotyping of humans allows information to be captured on the interactions between dietary, xenobiotic, other lifestyle and environmental exposures, and genetic variation, which together influence the balance between health and disease risks at both individual and population levels. OBJECTIVES: We describe here the main procedures in large-scale metabolic phenotyping and their application to metabolome-wide association (MWA) studies. METHODS: By use of high-throughput technologies and advanced spectroscopic methods, application of metabolic profiling to large-scale epidemiologic sample collections, including metabolome-wide association (MWA) studies for biomarker discovery and identification. DISCUSSION: Metabolic profiling at epidemiologic scale requires optimization of experimental protocol to maximize reproducibility, sensitivity, and quantitative reliability, and to reduce analytical drift. Customized multivariate statistical modeling approaches are needed for effective data visualization and biomarker discovery with control for false-positive associations since 100s or 1,000s of complex metabolic spectra are being processed. CONCLUSION: Metabolic profiling is an exciting addition to the armamentarium of the epidemiologist for the discovery of new disease-risk biomarkers and diagnostics, and to provide novel insights into etiology, biological mechanisms, and pathways.
BACKGROUND: Metabolic phenotyping of humans allows information to be captured on the interactions between dietary, xenobiotic, other lifestyle and environmental exposures, and genetic variation, which together influence the balance between health and disease risks at both individual and population levels. OBJECTIVES: We describe here the main procedures in large-scale metabolic phenotyping and their application to metabolome-wide association (MWA) studies. METHODS: By use of high-throughput technologies and advanced spectroscopic methods, application of metabolic profiling to large-scale epidemiologic sample collections, including metabolome-wide association (MWA) studies for biomarker discovery and identification. DISCUSSION: Metabolic profiling at epidemiologic scale requires optimization of experimental protocol to maximize reproducibility, sensitivity, and quantitative reliability, and to reduce analytical drift. Customized multivariate statistical modeling approaches are needed for effective data visualization and biomarker discovery with control for false-positive associations since 100s or 1,000s of complex metabolic spectra are being processed. CONCLUSION: Metabolic profiling is an exciting addition to the armamentarium of the epidemiologist for the discovery of new disease-risk biomarkers and diagnostics, and to provide novel insights into etiology, biological mechanisms, and pathways.
Authors: Hector C Keun; Timothy M D Ebbels; Henrik Antti; Mary E Bollard; Olaf Beckonert; Götz Schlotterbeck; Hans Senn; Urs Niederhauser; Elaine Holmes; John C Lindon; Jeremy K Nicholson Journal: Chem Res Toxicol Date: 2002-11 Impact factor: 3.739
Authors: Olivier Cloarec; Marc-Emmanuel Dumas; Andrew Craig; Richard H Barton; Johan Trygg; Jane Hudson; Christine Blancher; Dominique Gauguier; John C Lindon; Elaine Holmes; Jeremy Nicholson Journal: Anal Chem Date: 2005-03-01 Impact factor: 6.986
Authors: Par Jonsson; Stephen J Bruce; Thomas Moritz; Johan Trygg; Michael Sjöström; Robert Plumb; Jennifer Granger; Elaine Maibaum; Jeremy K Nicholson; Elaine Holmes; Henrik Antti Journal: Analyst Date: 2005-03-22 Impact factor: 4.616
Authors: Mary C Playdon; Regina G Ziegler; Joshua N Sampson; Rachael Stolzenberg-Solomon; Henry J Thompson; Melinda L Irwin; Susan T Mayne; Robert N Hoover; Steven C Moore Journal: Am J Clin Nutr Date: 2017-06-28 Impact factor: 7.045
Authors: Eline H van Roekel; Erikka Loftfield; Rachel S Kelly; Oana A Zeleznik; Krista A Zanetti Journal: Metabolomics Date: 2019-01-07 Impact factor: 4.290
Authors: Mia M Gaudet; Roni T Falk; Robert D Stevens; Marc J Gunter; James R Bain; Ruth M Pfeiffer; Nancy Potischman; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Montserrat Garcia-Closas; Christopher B Newgard; Mark E Sherman Journal: J Clin Endocrinol Metab Date: 2012-06-22 Impact factor: 5.958
Authors: Maik Pietzner; Ina Lehmphul; Nele Friedrich; Claudia Schurmann; Till Ittermann; Marcus Dörr; Matthias Nauck; René Laqua; Uwe Völker; Georg Brabant; Henry Völzke; Josef Köhrle; Georg Homuth; Henri Wallaschofski Journal: Thyroid Date: 2014-11-24 Impact factor: 6.568
Authors: Rachel S Kelly; Matthew G Vander Heiden; Edward Giovannucci; Lorelei A Mucci Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-04-06 Impact factor: 4.254